2009•Zhongliu fangzhi yanjiuOpen access

Expression of cyclooxygenase-2 (COX-2) in breast cancer and effects of COX-2 inhibitor Celecoxib on proliferation and apoptosis of breast cancer cell lines.

Yuqing Liu, Yuanyuan Li, Wentong Li

Open full text 0 citations

Abstract

Objective To approach whether Celeoxib could be used to cure breast cancer,the protein and mRNA level of COX-2 in breast cancer tissues and breast cancer cell lines MCF-7 and B37 was detected,and MCF-7 cells were cultured with Celecoxib to observe the effect of Celecoxib on proliferation and apoptosis of breast cancer cell lines.Methods Immunohistochemical staining,in situ hybridization and RT-PCR were used to detect the expression of COX-2 protein and mRNA in breast cancer tissues and breast cancer cell lines MCF-7 and B37;MTT assay and AO/EB double-staining were used to show effect of Celecoxib on proliferation and apoptosis of breast cancer cell lines.Results COX-2 protein mRNA could be detected in both the breast cancer cell lines MCF-7 and B37,and 52.3% of breast cancer tissues could express COX-2 protein;Celecoxib could inhibited MCF-7 cell growth in a concentration and time-dependent manner,and could lead to the 38.5% cell apoptosis of MCF-7 cell.Conclusion Breast cancer cell lines MCF-7,B37 and breast cancer tissues expressed COX-2;Celecoxib could inhibit breast cancer cell proliferation and induce apoptosis,with indicating that Celecoxib can be used as a new chemical drug treatment for breast cancer.

About this research paper

What this paper is about

Objective To approach whether Celeoxib could be used to cure breast cancer,the protein and mRNA level of COX-2 in breast cancer tissues and breast cancer cell lines MCF-7 and B37 was detected,and MCF-7 cells were cultured with Celecoxib to observe the effect of Celecoxib on proliferation and apoptosis of breast cancer cell lines.Methods Immunohistochemical staining,in situ hybridization and RT-PCR were used to detect the expression of COX-2 protein and mRNA in breast cancer tissues and breast cancer cell lines MCF-7 and B37;MTT assay and AO/EB double-staining were used to show effect of Celecoxib on proliferation and apoptosis of breast cancer cell lines.Results COX-2 protein mRNA could be detected in both the breast cancer cell lines MCF-7 and B37,and 52.3% of breast cancer tissues could express COX-2 protein;Celecoxib could inhibited MCF-7 cell growth in a concentration and time-dependent manner,and could lead to the 38.5% cell apoptosis of MCF-7 cell.Conclusion Breast cancer cell lines MCF-7,B37 and breast cancer tissues expressed COX-2;Celecoxib could inhibit breast cancer cell proliferation and induce apoptosis,with indicating that Celecoxib can be used as a new chemical drug treatment for breast cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To approach whether Celeoxib could be used to cure breast cancer,the protein and mRNA level of COX-2 in breast cancer tissues and breast cancer cell lines MCF-7 and B37 was detected,and MCF-7 cells were cultured with Celecoxib to observe the effect of Celecoxib on proliferation and apoptosis of breast cancer cell lines.Methods Immunohistochemical staining,in situ hybridization and RT-PCR were used to detect the expression of COX-2 protein and mRNA in breast cancer tissues and breast cancer cell lines MCF-7 and B37;MTT assay and AO/EB double-staining were used to show effect of Celecoxib on proliferation and apoptosis of breast cancer cell lines.Results COX-2 protein mRNA could be detected in both the breast cancer cell lines MCF-7 and B37,and 52.3% of breast cancer tissues could express COX-2 protein;Celecoxib could inhibited MCF-7 cell growth in a concentration and time-dependent manner,and could lead to the 38.5% cell apoptosis of MCF-7 cell.Conclusion Breast cancer cell lines MCF-7,B37 and breast cancer tissues expressed COX-2;Celecoxib could inhibit breast cancer cell proliferation and induce apoptosis,with indicating that Celecoxib can be used as a new chemical drug treatment for breast cancer.

Key concepts: Celecoxib, Breast cancer, Apoptosis, MCF-7, Cancer research, Cancer, Cell growth, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of cyclooxygenase-2 (COX-2) in breast cancer and effects of COX-2 inhibitor Celecoxib on proliferation and apoptosis of breast cancer cell lines. — Research Paper | ScholarLens